Articles tagged with Gamma Knife Treatment
Craniopharyngiomas are managed effectively with stereotactic radiosurgery (SRS), which provides high-dose radiation to tumors while minimizing risks to surrounding tissues. Studies have shown comparable control rates to conventional radiotherapy, but SRS is associated with lower incidence of hypothalamic obesity and long-term sequelae.
This study evaluated the long-term outcomes of gamma knife radiosurgery (GKRS) in patients with grade 2 meningiomas. GKRS was found to be a reasonable treatment option, but higher margin doses were associated with improved local control rates.
The new technology streamlines creation of radiation treatment plans for brain tumors and other diseases, reducing time from 1.5-3 hours to just one minute while maintaining accuracy. This frees medical professionals to focus on patient care and improving outcomes.
A new study found that treatment using Gamma Knife radiosurgery is often safer than leaving untreated AVMs, particularly for patients with a high life expectancy. The research suggests that younger patients are more likely to benefit from treatment, with a 10-year life expectancy of 50 years or more.
Dr. Nicole McLaughlin is conducting a first-of-its-kind study on patients with OCD undergoing gamma knife radiosurgery to measure brain connectivity before and after the procedure. The goal is to understand the neural mechanisms of therapeutic change and develop novel therapies for OCD and related anxiety disorders.
Stereotactic radiosurgery is an effective and safe method for eliminating tremors caused by Parkinson's disease and essential tremor. Long-term results show that SRS favorsably compares to deep brain stimulation and radiofrequency treatments in terms of tremor relief and complications.
Researchers found that nearly 98% of patients with early-stage non-small cell lung cancer who are unable to undergo surgery experienced no growth of the disease after three years. Additionally, over half of these patients lived for three years after diagnosis, while fewer than 20% experienced a serious decline in health status.
The study found that stereotactic body radiation therapy (SBRT) stopped the growth of lung cancer at its original site for nearly 98% of patients with early non-small cell lung cancer. Researchers also discovered that less than 20% of frail patients experienced a serious decline in health status after treatment.
The Gamma Knife treatment has been shown to provide significant pain relief and quality of life improvements for over 90% of patients with trigeminal neuralgia. Facial numbness was a common side effect, but its impact on daily life was often less severe than the debilitating pain it replaced.